{"entity":{"type":"insider","cik":"0001880129","url":"/insider/0001880129","json_url":"/insider/0001880129.json","name":"KENNEY CHRISTOPHER JOHN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2022-01-21","last":"2026-03-13","span_basis":"filed_date"},"name_variants":[{"name":"KENNEY CHRISTOPHER JOHN","source":"filing","n_filings":4,"first_seen":"2022-01-21","last_seen":"2026-03-13"}],"transactions":[{"id":5809784,"accession":"0001193125-26-106727","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-106727","line_url":"/filing/0001193125-26-106727#line-2","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001880129","owner_name":"KENNEY CHRISTOPHER JOHN","owner_display_name":"KENNEY CHRISTOPHER JOHN","owner_url":"/insider/0001880129","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1410.0,"shares_display":"1,410","price_per_share":55.225,"price_display":"55.22","price_state":"stated","total_value":77867.25,"total_display":"77,867.25","total_whole":"77,867","shares_owned_after":7069.0,"shares_owned_after_display":"7,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-13","filed_date":"2026-03-13","scope":"insider"},{"id":5770871,"accession":"0001193125-26-102669","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-102669","line_url":"/filing/0001193125-26-102669#line-2","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001880129","owner_name":"KENNEY CHRISTOPHER JOHN","owner_display_name":"KENNEY CHRISTOPHER JOHN","owner_url":"/insider/0001880129","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2771.0,"shares_display":"2,771","price_per_share":60.108,"price_display":"60.11","price_state":"stated","total_value":166559.268,"total_display":"166,559.27","total_whole":"166,559","shares_owned_after":4729.0,"shares_owned_after_display":"4,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-11","scope":"insider"},{"id":7897353,"accession":"0001209191-23-021136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-021136","line_url":"/filing/0001209191-23-021136#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001880129","owner_name":"KENNEY CHRISTOPHER JOHN","owner_display_name":"KENNEY CHRISTOPHER JOHN","owner_url":"/insider/0001880129","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":24507.0,"total_display":"24,507.00","total_whole":"24,507","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-24","filed_date":"2023-03-24","scope":"insider"},{"id":6423352,"accession":"0001209191-22-004460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-004460","line_url":"/filing/0001209191-22-004460#line-1","is_derivative":false,"issuer_cik":"0001582313","issuer_name":"Xenon Pharmaceuticals Inc.","issuer_ticker":"XENE","issuer_name_source":null,"issuer_url":"/issuer/0001582313","owner_cik":"0001880129","owner_name":"KENNEY CHRISTOPHER JOHN","owner_display_name":"KENNEY CHRISTOPHER JOHN","owner_url":"/insider/0001880129","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":28.81,"price_display":"28.81","price_state":"stated","total_value":20167.0,"total_display":"20,167.00","total_whole":"20,167","shares_owned_after":700.0,"shares_owned_after_display":"700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-21","filed_date":"2022-01-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001582313","name":"Xenon Pharmaceuticals Inc.","url":"/issuer/0001582313","role":"Officer (Chief Medical Officer)","n_filings":4,"first_seen":"2022-01-21","last_seen":"2026-03-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001880129","retrieved_at":"2026-08-26T21:27:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}